Debio1347, an Oral FGFR Inhibitor: Results From a Single-Center Study in Pediatric Patients With Recurrent or Refractory FGFR-Altered Gliomas. Article uri icon

Overview

publication date

  • May 20, 2021

Research

keywords

  • Benzimidazoles
  • Brain Neoplasms
  • Glioma
  • Pyrazoles
  • Receptors, Fibroblast Growth Factor

Identity

PubMed Central ID

  • PMC8232545

Scopus Document Identifier

  • 85117694897

Digital Object Identifier (DOI)

  • 10.1200/PO.20.00444

PubMed ID

  • 34250399

Additional Document Info

volume

  • 5